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Background: Isoflurane is the only volatile anaesthetic agent licensed for
equine use in the United Kingdom, but sevoflurane is also commonly used.
The two agents have rarely been compared for use in clinical elective surgery.
Methods: This single centre, prospective, randomised, blinded clinical inves-
tigation recruited 101 healthy client owned horses undergoing elective
surgery. Anaesthesia was standardised and horses randomly assigned to
receive isoflurane (I) or sevoflurane (S) for maintenance of anaesthesia in
100% oxygen. Horses were ventilated to normocapnia and received intra-
venous fluid therapy and haemodynamic support with dobutamine to main-
tain mean arterial blood pressure above 60 mm Hg. Recovery was timed
and video-recorded to allow offline evaluation by two experienced clinicians
unaware of the volatile agent used. No post-anaesthetic sedation was admin-
istered.
Results: There was no significant difference between groups in terms of
haemodynamic support required during anaesthesia nor in quality or dura-
tion of recovery. Inotropic support to maintain MAP above 60 mm Hg was
required by 67 of 101 (67%) of horses. Five horses in the I group required addi-
tional ketamine or thiopentone to improve the plane of anaesthesia.
Conclusions: Haemodynamic support needed during anaesthesia as well as
the duration and quality of recovery were similar with isoflurane and sevoflu-
rane.
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INTRODUCTION
One of the first published studies performed using
sevoflurane in horses concluded that the drug was
straightforward to use and suitable for horses under-
going surgery.1 The study evaluated the use of sevoflu-
rane in 40 equids undergoing surgery following a com-
bination of intravenous anaesthetic protocols. The
depth of anaesthesia was easy to control, and recovery
was generally very satisfactory, although intravenous
xylazine was often included. Cardiopulmonary func-
tion and biochemical effects with sevoflurane anaes-
thesia were similar to isoflurane2; these findings were
supported by other similar studies at the time.3,4
A small scale study in Arabian horses not under-
going surgery concluded that the quality of recov-
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ery was superior following sevoflurane compared to
isoflurane5 but this again involved xylazine in the pro-
tocol. The longer lasting alpha 2 agonists were not
in widespread use at that time. The use of sevoflu-
rane was more widespread in Japan compared to the
USA, Canada and Europe resulting in early publica-
tions and research from that country defining the
sevoflurane minimum alveolar concentration (MAC)
in horses. The MAC for sevoflurane in horses has been
reported as 2.31%6 and 2.84%7 and its cardiovascular,
pulmonary effects8,9 and influence on biochemistry
values have also been studied.7 Sevoflurane decreased
mean arterial blood pressure, cardiac output, stroke
volume, respiratory rate (RR) and minute volume in
a dose-dependent manner8 similar to those changes
seen with isoflurane. One study reported that horses
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anaesthetised with sevoflurane may require less
inotropic support for maintenance of blood pressure10
which may be due to less suppression of vasomo-
tor tone by sevoflurane compared to isoflurane. Fur-
thermore the low blood/gas solubility of sevoflurane
(0.69 compared to 1.38 for isoflurane) and low tissue
solubility11 should produce more rapid control of the
depth of anaesthesia and rapid recovery, often desir-
able in equine anaesthesia. One more recent study
in 77 horses undergoing general anaesthesia for MRI
showed no difference in quality of recovery between
isoflurane and sevoflurane; however, this study did not
involve surgery and may have been underpowered to
detect differences in recovery quality.12 The aim of our
study was to compare the course of anaesthesia and
recovery in horses anaesthetised with isoflurane or
sevoflurane for elective surgery under the conditions
of conventional clinical equine practice.
MATERIALS AND METHODS
Study design
The study was designed as a prospective, randomised,
blinded, controlled clinical trial. It was conducted
under an Animal Test Certificate (ATC-S-107) and
approval from the University of Nottingham, School
of Veterinary Medicine and Science ethics commit-
tee (2631 181108). The study was undertaken at one
equine hospital in the United Kingdom. Following
informed client consent, horses were allocated to
receive isoflurane (I) or sevoflurane (S) for mainte-
nance of anaesthesia using a pre-prepared randomisa-
tion chart (GraphPad QuickCalcs 2019). Recovery from
anaesthesia was filmed, and two experienced ECVAA
diplomate anaesthetists not involved with the cases
and unaware of the volatile agent used awarded the
recovery score for each case.
Animals
A sample size calculation indicated that 46 horses
per group would be required to show a statistically
significant clinically relevant difference. It was esti-
mated that the size of the sample should be at least
92 horses to have an 80% power and 95% confidence
level of detecting a 33% difference in recovery scores
as assessed by a 0–5 Simple Descriptive Scale based
on pilot studies, using an ordinal logistic regression
model relying on a proportional odds assumption.
Sample size calculation was performed using G*power
(G*power 3.1).13 The inclusion criteria for entry into
the trial were defined as elective surgical cases in
horses or ponies older than 6 months that had not
received sedation in the preceding 24 h.
All horses were allowed access to hay and water
until they were brought to the preparation area 45
min before induction of general anaesthesia. Patients
were weighed and underwent a full clinical examina-
tion prior to premedication. All were classified as ASA 1
under the American Society of Anaesthesiologists clas-
sification.
Anaesthesia premedication
A 12-gauge intravenous catheter (Intraflow, Vygon
Ltd) was secured in a jugular vein. At least
30 min prior to induction of anaesthesia, all horses
received 0.03 mg/kg of acepromazine (Neurotranq,
Alfasan) and 1.1 mg/kg of flunixin (Pyroflam, Nor-
brook) intravenously (i.v.). Perioperative antibiotics
were determined by the clinician in charge of the
case and consisted of 12 mg/kg procaine benzylpeni-
cillin (Depocillin, MSD) intramuscularly (i.m.) with
or without 6.6 mg/kg of gentamicin (Genta-Equine,
Dechra) or 5 mg/kg oxytetracycline (Engemycin) i.v.
Ten minutes before induction 80 mcg/kg romifi-
dine (Sedivet, Boehringer Ingelheim) and 0.2 mg/kg
morphine (Morphine sulphate, Martindale Pharma-
ceuticals) were administered i.v., and the horse was left
undisturbed.
Anaesthesia induction and maintenance
Anaesthesia was induced with an i.v. bolus of
0.06 mg/kg diazepam (Diazepam injection BP) and
3 mg/kg ketamine (Ketavet, Zoetis UK Ltd) and horses
became recumbent without manual restraint. Once
the horse was laterally recumbent, the trachea was
intubated with an appropriately sized cuffed, silicone
endotracheal tube and connected to a large animal
anaesthetic machine (JD LAVC 2000, JD Medical).
Horses were mechanically ventilated (Bird Mark 7, JD
Medical Phoenix USA) with a positive inspiratory pres-
sure of 15–20 cmH2O, a tidal volume of 10−12 ml/kg
and a RR chosen by the anaesthetist to maintain end
tidal carbon dioxide pressures (PE’CO2) of 40−45 mm
Hg (5.3−6.0 kPa). Anaesthesia sufficient for the surgi-
cal procedure was maintained with isoflurane (Isoflo,
Zoetis UK Ltd) or sevoflurane (Sevoflo, Zoetis UK Ltd)
in oxygen. Vaporiser settings were selected to maintain
end tidal isoflurane (FE’ISO) between 1%−1.5% and
end tidal sevoflurane (FE’SEVO) between 2%−2.5%.
Lactated Ringer’s solution (Vetivex (Hartmann’s) 11,
Dechra) was infused i.v. at 5 ml/kg/h for the first hour
and then 2 ml/kg/h thereafter. Dobutamine solution
(Dobutamine concentrate, Hamelm Pharmaceuticals)
was infused (HK-100VET infusion pump, VETisco) to
horses requiring haemodynamic support to maintain
mean arterial blood pressure (MAP) above 60 mm Hg
using a prepared rate scale starting at 0.25 µg/kg/min
to a maximum of 2 µg/kg/min. The total amount of
dobutamine administered over the duration of the
anaesthetic was recorded. A urinary catheter was
placed in all horses before surgery started. If the
horse developed nystagmus or moved a ketamine or
thiopentone i.v., bolus was administered to improve
the plane of anaesthesia.
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T A B L E 1 Recovery score. The number of attempts to stand
was also counted, and a free text box was available for comments
Recovery
score Description
0 Very violent (‘wall of death’) self-inflicted injury,
prolonged struggling, unable to stand after the end of
anaesthesia
1 Excitement when recumbent, persistent unsuccessful
attempts to stand, severe ataxia and falls once
standing, aimless walking, high risk of self-inflicted
injury
2 Excitement paddling when recumbent, several attempts
to stand, severe ataxia when standing, danger of
self-inflicted injury
3 Some staggering and ataxia, a few unsuccessful attempts
to stand, ataxic immediately after standing up
4 Slight ataxia and staggering, stood up at first/second
attempt, no serious instability
5 No ataxia, no struggling, stood up at first attempt as if
fully conscious
Monitoring
A 22 or 20-gauge catheter (Intraflow, Vygon) was
placed in a facial or dorsal metatarsal artery for arte-
rial blood pressure measurement. Heart rate, systolic
(SAP), mean (MAP) and diastolic (DAP) blood pres-
sure, RR, and arterial oxygen haemoglobin satura-
tion (SPO2), end tidal expired carbon dioxide pressure
(PE’CO2) were continuously displayed using a multi-
parameter monitor (Lightning Multiparameter Moni-
tor, Vetronic) and manually recorded every 5 min. End
tidal volatile agent and carbon dioxide values (FE’ISO,
FE’SEVO, PE’CO2) were measured separately (Masimo
ISA agent monitor, Masimo). Monitoring devices were
calibrated prior to use according to the manufacturer’s
instructions.
Anaesthesia recovery
At the end of surgery horses were moved into a padded
recovery box. Ventilation was assisted using a demand
valve (Oxygen Demand Valve, JD Medical Phoenix
USA) until spontaneous respiration resumed. Once
spontaneous ventilation was deemed satisfactory by
the attending anaesthetist, the endotracheal tube was
removed and the horse left to recover unassisted. The
entire recovery phase was timed and scored by the
attending anaesthetist and filmed by a camera (Dahua
IP Camera system) situated above the recovery box.
Films were saved as MP4 files and stored securely for
off-line analysis by two anaesthetists (KW and PT)
unaware of the volatile agent used. The time from
disconnection to extubation, sternal recumbency and
standing were recorded. The quality of the anaesthe-
sia recovery was evaluated using a previously reported
recovery score system for horses14 from 5 being the
best to 0 being the worst (Table 1). The authors dis-
cussed and agreed on the application of the scoring
system, and several ’practice runs’ were undertaken
on clinical cases anaesthetised before the trial began.
Data analysis
The normality of the data was evaluated using the
D’Agostino and Pearson test. Categorical data were
analysed using Fisher’s exact test or chi-square, and
kappa was calculated for inter-rater reliability. Contin-
uous data and physiological variables were analysed
using the unpaired Students’ t test for normally dis-
tributed data or the Mann-Whitney U test for non-
parametric data. A general linear regression model was
used to analyse recovery score data with the different
observers as the within-subjects factor and the volatile
agent as the between-subjects factor. Differences were
considered significant when p ≤ 0.05.
RESULTS
One hundred and three horses were recruited to the
study between February and November 2019. Two
horses were excluded because the recovery films were
not available. The final analysis included 49 horses
who received isoflurane and 52 who received sevoflu-
rane.
There were no significant differences between the
groups for age, bodyweight, sex, duration of surgery,
duration of anaesthesia, type of surgery, position of
horse during anaesthesia or antibiotic administration.
The demographics of the horses are summarised in
Table 2.
MAC multiples at each time point were calculated
as end tidal volatile agent divided by the MAC of the
volatile agent. Averaged MAC multiples for I and S
groups were different (p < 0.0001), but there was no
difference at the final reading prior to disconnection
(p = 0.05). When averaged over the entire anaesthetic,
total anaesthetic exposure calculated as MAC hours
was very similar between groups (Table 3). Four horses
in the I group required additional doses of ketamine
(p = 0.04), and one horse received thiopentone. There
was no significant difference between groups for the
number of horses receiving dobutamine or the µg/kg
infused (p = 0.2). One horse in each group received a
phenylephrine infusion to increase arterial blood pres-
sure, in both cases for less than 20 min. Notwithstand-
ing the infusion of dobutamine and phenylephrine,
a hypotensive index can also be calculated to quan-
tify the magnitude and duration of hypotension occur-
ring below a pre-determined value. The hypotensive
indexes for blood pressure below 60 and 70 mm Hg
were also calculated. There were no differences in
cardiopulmonary variables between I and S groups
(Table 4).
The median time to extubation was identical in
both groups, but the range was significantly different.
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T A B L E 2 Demographic data, procedural times and types of surgery of horses undergoing anaesthesia maintained with isoflurane
(n = 49) or sevoflurane (n = 52)
Isoflurane (I) n = 49 Sevoflurane (S) n = 52 95% CI p value







Pony (Connemara, Welsh) 6 6
Cob 4 4
Standardbred 1 0
Thoroughbred and thoroughbred x 2 6
Warmblood (Hannovarian, Holsteiner, Sport
Horse)
26 20
Irish Sport Horse 5 12
Irish Draft Horse 3 0
Arab 0 1
Unspecified 2 3
Weight (kilogrammes) 578 (288−706) 570 (370−752) −24–40 0.7
Duration of anaesthesia (minutes) 100 ± 30 106 ± 26 −4.6–17.4 0.7
Duration of surgery (minutes) 45 (10−100) 40 (10−100) −15–5 0.2
Types of surgery N/A
Arthroscopy/tenoscopy/bursoscopy (1) 15 † 15 ‡
Arthroscopy/tenoscopy/bursoscopy (> 1) 12† 11
Neurectomy 4 8
Annular ligament desmotomy 3 1
Splint bone removal 0 1
Airway surgery 1 4
Sarcoid removal 2 1
Castration and cryptorchid surgery 1 3




Perioperative penicillin 17 12
Perioperative penicillin and gentamicin 28 36
Perioperative oxytetracycline 2 3
No perioperative antibiosis 2 1
Recumbency 0.1
Dorsal 29 § 34
Right lateral 12 6
Left Lateral 6 12
Unspecified 2 0
Normally distributed data are presented as mean ± SD and nonparametric data as median (minimum-maximum). p value was calculated for continuous data
using Student’s t test or Mann-Whitney test, and categorical data were compared using Fisher’s exact test or chi-square test. p value represents differences between
groups, and confidence intervals (CI) are calculated for that difference.
†One horse had an additional procedure.
‡Two horses had an additional procedure.
§Two horses in the I group were moved from dorsal to right and left lateral recumbency during anaesthesia.
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T A B L E 3 Anaesthetic data for the two groups of horses. Values are expressed as mean ± SD or median (minimum-maximum). p value
represents differences between groups, and confidence intervals (CI) are calculated for that difference
Isoflurane (I) Sevoflurane (S) 95% CI p value
Dobutamine dose (µg/kg/min) infused
during anaesthesia
0.3 (0.04−0.6) n = 35 0.2 (0.02−0.6) n = 32 −0.1−0.02 0.2
Additional ketamine (mg/kg) 0.8 (0.6−2.2) n = 4 0 0 0.04
Additional thiopentone (mg/kg) 0.75 n = 1 0 N/A N/A
End tidal volatile agent (%) 1.2 (0.8−1.5) n = 49 2.2 (1.8−2.6) n = 52 N/A N/A
MAC multiple 0.9 (0.6−1.1) n = 49 1.0 (0.8−1.8) n = 52 0.03–0.08 < 0.0001
MAC multiple at disconnection 0.9 (0.6−1.1) n = 49 1.0 (0.9−1.1) n = 52 0–0.07 0.05
MAC hours 1.3 ± 0.4 n = 49 1.3 ± 0.4 n = 52 −0.2–0.1 0.8
MAC multiples were calculated as end tidal volatile agent divided by isoflurane MAC of 1.3 vol%15 or a sevoflurane MAC of 2.3 vol6.
MAC hour was calculated as (average end-expired volatile agent concentration/MAC Volatile agent) x hours of volatile agent anaesthesia) based on an isoflurane MAC
of 1.3 vol%15 and a sevoflurane MAC of 2.3 vol%6.
Abbreviation: MAC, minimum alveolar concentration.
T A B L E 4 Cardiopulmonary data for the two groups of horses
Isoflurane (I) Sevoflurane (S) 95% CI p value
Heart rate (beats per minute) 35 (20−62) 34 (26-76) −3.7–0.05 0.05
PE’ CO2 (mm Hg) 39 (26-48) 39 (24-58) −2–1 0.8
SpO2 (%) 98 (67-100) 98 (74-100) −0.2–0.4 0.2
Hypotensive index 60 (mm Hg/Hr) † 1.8 (0.05−17.4) n = 13 0.6 (0.05−21) n = 21 −4.6–0.5 0.4
Hypotensive index 70 (mm Hg/Hr) ‡ 6.5 (0.05−45.9) n = 44 11 (0.1−42.3) n = 38 −0.3–6.3 0.09
Normally distributed data are presented as mean± SD and nonparametric data as median (minimum-maximum). p value represents differences between groups,
and confidence intervals (CI) are calculated for that difference.
†Hypotensive index = (60-lowest mean blood pressure) x time in hours the mean blood pressure was less than 60.
‡Hypotensive index = (70-lowest mean blood pressure) x time in hours the mean blood pressure was less than 70.
Horses in the S group attained sternal recumbency
later than the I group (p = 0.03), but no difference in
the time taken to stand or attempts to stand were dis-
cernible (Table 5).
Normally distributed data are presented as mean
± SD and nonparametric data as median (minimum-
maximum). p value was calculated for continu-
ous data using Student’s t test or Mann-Whitney
test. p value represents differences between groups,
and confidence intervals are calculated for that
difference
There was no significant difference in recovery
score between the I or S groups for either of the
blinded observers (Rater A and B) and the attend-
ing anaesthetist aware of the volatile agent used.
Inter-rater agreement (kappa) for recovery scores for
the two blinded observers was almost perfect for I
(0.83) and S (0.84). Scores are summarised in Table 6,
and a histogram of the distribution of the recovery
scores for the observers is shown in Figure 1. Free
text comments associated with the recovery scoring
indicated that a few horses in both groups (9 I, 10
S) had repeated, frantic, unsuccessful attempts to
stand. One horse (Group I), a 7-month-old warm-
blood was euthanised after a prolonged recovery and
a tentative diagnosis of spinal cord malacia. The
horse had undergone a stifle arthroscopy in dorsal
recumbency.
DISCUSSION
This clinical prospective blinded comparison of the
recovery of horses from isoflurane or sevoflurane
anaesthesia found no significant difference in the
quality of recovery or the haemodynamic support
required. The clinical nature of the study deserves
emphasis; it is a true representation of equine surgery
and anaesthesia in a UK practice. The results are in
agreement with the non-surgical clinical study com-
paring recovery after sevoflurane or isoflurane anaes-
thesia for MRI.12
Haemodynamic support did not differ between the
groups; the hypotensive indexes which can be con-
sidered an outcome measure of the support given
indicate group effects. Of the horses in the I group,
90% (44/49) experienced a period of time with mean
blood pressure below 70 mm Hg in comparison to
73% (38/52) in the S group. For decades, equine
anaesthetists have been acutely aware of the rela-
tionship between hypotension and reduced muscle
perfusion,16,17 hence the emphasis on correct posi-
tioning of the horse, padding and limiting hypotension
during anaesthesia. Nevertheless, while the infusion
of inotropes and vasopressors may mitigate against
hypotension, this does not guarantee adequate mus-
cle perfusion. No cases of post-anaesthetic myopathy
were recorded in this cohort, and this may also be a
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T A B L E 5 Recovery characteristics of horses after isoflurane or sevoflurane anaesthesia
Isoflurane Sevoflurane 95% CI p value
Attempts to stand 4 (1−25) 4 (1−17) −2–1 0.5
Time to extubation (minutes) 5 (1−10) 5 (2−11) 0–2 0.02
Time to sternal (minutes) 18 (5−53) 21 (2−44) 0–6 0.03
Time to standing (minutes) 29 ± 11 32 ± 10 −1.2–7 0.2






observer Rater B p value
Isoflurane 3 (0−5) 3 (0−5) 3 (0−5) 0.4
Sevoflurane 4 (2−5) 3 (2−5) 3 (1−5) 0.8
function of the relative vasodilation caused by isoflu-
rane and sevoflurane8,18 in contrast to the vasocon-
striction incurred by horses receiving halothane in the
past.
Additional ketamine and thiopentone boli were only
administered to horses in the I group. This might stem
from easier control of the plane of anaesthesia with
the less soluble sevoflurane as a result of the faster rate
of response to change19 thereby reducing the need for
injectable anaesthetics. It might also indicate that the
I horses were maintained at a lighter plane of anaes-
thesia. However, most horses in the I group did not
require ’top-ups’, and all surgery was completed suc-
cessfully making the latter reason of limited clinical
significance. The horses that received the ketamine
and thiopentone boli underwent different procedures
and had recoveries that ranged in quality from excel-
lent (5) to requiring euthanasia (0). The horse requir-
ing euthanasia in this study cohort results in a 1%
death rate, as for other studies,20,21 and a retrospective
evaluation of all anaesthesia deaths in elective cases
in the preceding 7 years at this one centre was found
to be 0.6% (John F. R. Hird, personal communication).
The aetiology of spinal cord malacia is still debated,
but the cases reported in the literature include mostly
large breed young male horses undergoing surgeries in
dorsal recumbency, and spinal cord ischaemia is pre-
sumed to occur during the procedure.22 Although this
particular horse had a hypotensive (60) index of 5 and
a hypotensive (70) index of 31.3 which may have been
a factor, its haemodynamic record was not out with the
range of whole group.
The debate about the quality of equine recovery
from anaesthesia has persisted since isoflurane super-
seded halothane and became the agent of choice
because of less deleterious haemodynamic effects23,24
and liver toxicity for patients and theatre staff.25,26 In
order to compare the recovery from the two volatile
agents meaningfully, careful consideration was given
to standardising the protocol while maintaining a typ-
ical clinical caseload and choosing a suitable sample
size. Recording of the recovery ensured all aspects of
the process could be scrutinised, timed and scored
without bias. The recovery scores of the attending
anaesthetists were higher for sevoflurane recoveries
than the blinded scorers, potentially indicating a pref-
erence for sevoflurane over isoflurane. Equine anaes-
thesia recovery is often characterised by emergence
delirium and violent uncoordinated attempts to stand;
the most common causes of death are the devastat-
ing fractures occurring in recovery.20 It is postulated,
at least in humans, that residual volatile agent in the
brain may be responsible for a breakdown in intra-
cortical and thalamocortical connectivity sufficient to
facilitate dysphoria but insufficient to produce immo-
bility and unconsciousness.27
There is hysteresis between the anaesthetic par-
tial pressure in the CNS and the alveolar anaesthetic
partial pressure (P AA) in the lung; consequently,
strategies aimed at improving recovery quality from
F I G U R E 1 Histogram of recovery scores assigned by two experienced anaesthetists (Rater A and B) unaware of the volatile agent
delivered during the anaesthesia. Recovery score is 0 (worst) to 5 (best)
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inhaled agents can include promoting alveolar ven-
tilation in order to decrease PAA as much as possible
before the horse starts to move.28 Administration of
alpha 2 agonists during recovery can reduce alveo-
lar ventilation and prolong recumbency29 hence the
current study design omitting this intervention with
the aim of parsing out the recovery characteristics of
the two volatile agents. The lower blood gas solubility
of sevoflurane in theory should produce a shorter
recovery time compared to isoflurane,5,30,31 but in fact
in both this current study and others4,28 this was not
the case, since it is assumed the predicted advantage
is negated by the greater respiratory depression as
a result of the sevoflurane. Furthermore, studies of
volatile agents in rodents show these discrepancies
can also be explained by the anaesthetics having dif-
ferent neural endpoints for amnesia, immobility,32,33
proprioception, hyperalgesia and in humans higher
cognitive functions. Horses took longer to reach ster-
nal recumbency after sevoflurane than isoflurane. It
seems unlikely that they were at a deeper plane of
anaesthesia at disconnection as MAC multiples were
the same at this point. It may reflect the alleged calmer
recovery from sevoflurane compared with isoflurane,5
although the final result was not different. A common
approach to the potential for horses trying to stand
before regaining normal cognition is to sedate the
horses in recovery in order to control for the vari-
able neural endpoints under the assumption that a
longer period in lateral or sternal recumbency would
ensure that the horse has passed the time period
during which numerous uncoordinated attempts
to stand occur. The 19 (9 I, 10 S) horses which had
repeated, frantic, unsuccessful attempts to stand
may have benefitted from sedation. Future studies
incorporating standardised post-operative sedation
comparing isoflurane with sevoflurane, and possibly
desflurane in large clinical caseloads are indicated.
Studies to date have shown sedation improves recov-
ery quality but prolongs duration.5,14,34 This may be
an attractive trade off, but in practical terms, may
not be universally viable since the sedated horse is
occupying the padded box for a longer period of time,
potentially resulting in surgical slow down, and fur-
ther lengthening the working day and increasing staff
costs.
A further limitation stems from the attending anaes-
thetists being inevitably aware which volatile anaes-
thetic was in use. Anaesthesia was provided by one
of four different anaesthetists who were aware which
volatile anaesthetic was in use. This may have intro-
duced bias because experience with a particular
anaesthetic may have led to slight differences in how
each was administered. However, sufficient depth
of anaesthesia for surgery within a narrow window
of vaporiser settings coupled with the need not to
depress cardiovascular function unnecessarily would
suggest this was a minor problem. Five I horses but no
S horses required IV supplementation with ketamine
or thiopentone. This might reflect a lighter plane of
anaesthesia in the I group, or as discussed above, the
need for more rapid change in the depth of anaesthe-
sia. It is also possible that it was simply a result of less
familiarity with isoflurane than sevoflurane; and the
need for a known rapid effect to ensure horses did not
move during surgery. There was some discrepancy in
the equality of MAC values between the groups, sug-
gesting that the isoflurane horses may have been at a
lighter plane of anaesthesia. The haemodynamic data
suggest that this difference was not marked, as the car-
diovascular support required was similar. Moreover,
the relevance of equal MAC in a clinical setting is ques-
tionable; response to surgery is more relevant. Murrell
et al35 showed in rats that ’equipotent’ concentrations
of isoflurane cause more burst suppression in the EEG
than sevoflurane. This demonstrates that the plane of
anaesthesia required for the mixed stimuli of surgery
may not be equivalent to MAC multiples. Rigid adher-
ence to equality of MAC in a clinical setting appears
less apposite than maintaining the best conditions for
surgery.
In conclusion, isoflurane and sevoflurane provide
similar anaesthetic conditions for elective surgeries.
Isoflurane anaesthetics required more ‘top ups’ of
ketamine and thiopentone. There was no difference
in the haemodynamic support required during anaes-
thesia or the recovery profiles. In view of the fact that
post-anaesthetic sedation is the standard of care at
some practices, future prospective studies incorporat-
ing these aspects are advised.
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